Skip to main content
Jennifer McNeer, MD, Pediatric Hematology & Oncology, Salt Lake City, UT

JenniferLynnMcNeerMD

Pediatric Hematology & Oncology Salt Lake City, UT

Professor of Pediatrics, University of Utah

Dr. McNeer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. McNeer's full profile

Already have an account?

  • Office

    81 N Mario Capecchi Dr
    5th Floor Oncology
    Salt Lake City, UT 84112
    Phone+1 801-662-4700
    Fax+1 801-662-4707

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 2006 - 2009
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2003 - 2006
  • New York University School of Medicine
    New York University School of MedicineClass of 2003

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 2023 - 2026
  • IL State Medical License
    IL State Medical License 2005 - 2023
  • IN State Medical License
    IN State Medical License 2010 - 2023
  • WI State Medical License
    WI State Medical License 2007 - 2009
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Inotuzumab Ozogamicin in Pediatric Patients with relapsed/refractory Acute Lymphoblastic Leukemia  
    Deepa Bhojwani, Constance Yuan, Jennifer L McNeer, Mignon L Loh, Vilmarie Rodriguez, Susan R Rheingold, Elizabeth A Raetz, Nature

Lectures

  • Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

  • Blinatumomab Added to Chemotherapy Improves Disease-Free Survival in Newly Diagnosed NCI Standard Risk Pediatric B-acute Lymphoblastic Leukemia: Results from the Randomized Children’s Oncology Group Study AALL1731December 2024

Press Mentions

  • 203 UChicago Medicine Doctors Named to 2022 Top Docs List
    203 UChicago Medicine Doctors Named to 2022 Top Docs ListJanuary 21st, 2022
  • Pediatric Sedation Program Helps Ease Patients' Anxiety – and Improve Hospital Workflow
    Pediatric Sedation Program Helps Ease Patients' Anxiety – and Improve Hospital WorkflowFebruary 3rd, 2020
  • Transplant No Help in Hypodiploid ALL
    Transplant No Help in Hypodiploid ALLMarch 29th, 2019
  • Join now to see all

Professional Memberships